PRKCA and melanoma: Differentiation markers of melanoma cells such as protein kinase Cα (PKCα) functioning in the proliferation and differentiation of cells are stimulated upon treatment with MEL (5 μM) for 48 h, indicating that the differentiation of B16 cells is triggered by MEL through the PKCα signaling pathway [44].